pacb (PACB) Analyst & Key Data

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

9

Hold

8

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$1.30

Median Target-9.23%

$1.18

Potential downside vs current price

Current Stock Price

$1.30

Median Target-9.23%

$1.18

Potential downside vs current price

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

9

Hold

8

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$1.30

Median Target-9.23%

$1.18

Potential downside vs current price

Current Stock Price

$1.30

Median Target-9.23%

$1.18

Potential downside vs current price

Pacific Biosciences of California, Inc.